|
CDCA4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.90259999977016E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.56680004923271E-09 |
| Normal-vs-Stage2 |
1.615500E-03 |
| Normal-vs-Stage3 |
3.757700E-04 |
| Normal-vs-Stage4 |
2.283700E-02 |
| Stage1-vs-Stage2 |
3.092400E-01 |
| Stage1-vs-Stage3 |
4.108800E-01 |
| Stage1-vs-Stage4 |
1.192550E-01 |
| Stage2-vs-Stage3 |
2.164200E-01 |
| Stage2-vs-Stage4 |
9.138000E-02 |
| Stage3-vs-Stage4 |
1.860210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.76350000002934E-06 |
| Normal-vs-AfricanAmerican |
1.77578999999151E-05 |
| Normal-vs-Asian |
1.621740E-02 |
| Caucasian-vs-AfricanAmerican |
4.808000E-01 |
| Caucasian-vs-Asian |
3.878600E-01 |
| AfricanAmerican-vs-Asian |
9.126000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.48490000000135E-05 |
| Normal-vs-Female |
5.97339999686142E-09 |
| Male-vs-Female |
2.303000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.30540000317947E-08 |
| Normal-vs-Age(41-60Yrs) |
3.70929999999881E-05 |
| Normal-vs-Age(61-80Yrs) |
9.154700E-04 |
| Normal-vs-Age(81-100Yrs) |
2.354200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.902800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.185600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.761590E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.327200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.030440E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.233790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.168710E-04 |
| Normal-vs-Grade 2 |
1.19280030297375E-10 |
| Normal-vs-Grade 3 |
2.4904999999964E-05 |
| Normal-vs-Grade 4 |
2.680300E-02 |
| Grade 1-vs-Grade 2 |
3.296800E-01 |
| Grade 1-vs-Grade 3 |
3.622000E-01 |
| Grade 1-vs-Grade 4 |
2.015400E-01 |
| Grade 2-vs-Grade 3 |
8.986800E-01 |
| Grade 2-vs-Grade 4 |
1.284020E-01 |
| Grade 3-vs-Grade 4 |
1.266960E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.55090001846747E-09 |
| Normal-vs-ccB subtype |
4.643800E-03 |
| ccA subtype-vs-ccB subtype |
1.372230E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.77390000000366E-05 |
| Normal-vs-N1 |
1.607960E-02 |
| N0-vs-N1 |
6.121800E-01 |
|
|
